Features
Latest Features
ACC, AHA Publish Appropriate Use Criteria Guidelines for Peripheral Artery Intervention
In publishing updated appropriate use criteria, the organizations hope to provide guidance to clinicians who may refer patients for revascularization therapy.
Navigating Social Media Issues in Medical Practice: An Expert Interview
Issues that affect employees in all industries are compounded by a unique set of additional concerns that affect employees of medical practices.
Questions Remain Regarding VTE Recurrence in Older Adults
Venous thromboembolism recurrence risk may not be any higher in older patients than in younger patients.
The Role of Viral Infections and Vaccines in the Pathogenesis of Antiphospholipid Syndrome
Recent evidence links specific bacterial, viral infections, and vaccination to the development of APS, but these associations are not clear-cut.
Should Infants Be Treated With vWF Concentrate After Cardiac Surgery?
Researchers comment on the implications of treating newborns and infants with von Willebrand factor (VWF) concentrate.
Investigating the Link Between Atrial Fibrillation and Type 2 Diabetes
Compared with the general population, patients with type 2 diabetes are at a 35% to 60% greater risk for atrial fibrillation.
Bipolar Disorder and the Cardiovascular System
Screening for cardiovascular disease risk is recommended for clinicians who manage patients with bipolar disorder.
Risk Factors for Atherosclerotic Cardiovascular Disease in the South Asian Population
South Asians exhibit the highest rates of ASCVD among all ethnic groups, and the highest prevalence is in younger age groups; up to 25% of myocardial infarctions in India occur in individuals younger than 40 years of age.
PCSK9 Inhibition: Benefits Outweigh Risks in Patients With Diabetes
Statin therapy is the first line of defense against high LDL-C and the risk for atherosclerotic cardiovascular disease, the leading cause of morbidity and mortality in individuals with diabetes.
ASPREE Trial: Aspirin Associated With Higher Mortality, Hemorrhage Risk in Older Adults
The use of aspirin in healthy elderly patients as a preventative strategy was associated with no prolongation of long-term disability-free survival compared with placebo.
Enrolling the Uninsured in Clinical Trials: Is it Ethical?
Until universal access to healthcare is ensured as a human right, researchers must keep important ethical concerns in mind when designing future clinical trials.
Doctors and the D Word: Talking About Death Is an Essential Skill — and One Often Lacking
The reasons for physicians' discomfort with conversations about dying are as much cultural, social, and systemic as they are personal.
Assessing the Evidence of Aspirin for Primary Prevention in Diabetes
The substantial burden of cardiovascular disease in patients with diabetes has led to the exploration of various cardiovascular disease prevention strategies, including the use of aspirin.
Nutraceuticals May Benefit Patients Who Are Statin Intolerant
Nutraceuticals may offer a solution to patients who cannot tolerate statins because of severe muscle pain.
The Uncertain Association Between Abacavir and the Risk for Acute Myocardial Infarction
A higher prevalence of traditional cardiovascular risk factors may be partially responsible for the increased incidence of cardiovascular disease in people living with HIV.
Supplementing Pulmonary Arterial Hypertension Therapy With Nutritional Changes
Current research suggests patients with pulmonary arterial hypertension may benefit from iron and vitamin D supplementation.
Hypertension Disorders in Pregnancy: The Potential of Prophylactic Aspirin
To aid in the prevention of preeclampsia, American College of Obstetricians and Gynecologists and the US Preventive Services Task Force recommend low-dose aspirin prophylaxis in patients with 1 or more high-risk factors.
Unraveling the Relationship Between COPD and Stroke
Although COPD has been identified as a risk factor for cardiovascular disease, researchers are less certain about the relationship between COPD and stroke.
Managing Cardiovascular Risk in Rheumatoid Cachexia
Because of the increased risk for cardiovascular disease in patients with rheumatoid arthritis, the increase in fat mass caused by rheumatoid cachexia can be especially concerning.
Improving Risk Stratification, Diagnostic Accuracy in PAH With Cardiopulmonary Exercise Testing
Cardiopulmonary exercise testing can be an important diagnostic and prognostic tool in pulmonary arterial hypertension.
The Cardiology Advisor Articles
- Should Guidelines Use Higher Risk Thresholds When Recommending Statins for Primary CVD Prevention?
- Ezetimibe Plus Statins Modestly Reduce Cardiovascular Disease Event Risk
- ACC, AHA Publish Appropriate Use Criteria Guidelines for Peripheral Artery Intervention
- FDA: E-Liquids Found to Contain Undeclared Sildenafil and Tadalafil
- Ultrasound-Based Visualization of Silent Atherosclerosis May Improve Medication Adherence
- ACC Releases Consensus Decision Pathway for CVD Risk Reduction in T2D and ASCVD
- Childhood Behavioral Interventions May Promote Adult Cardiovascular Health
- US Medical Schools Increase in Diversity After Implementation of Accreditation Standards
- Botox Injections Explored to Reduce Postop AF in Cardiac Surgery
- AHA Scientific Statement: Low Risk of Side Effects With Statins
- Do More Aggressive Periprocedural Antibiotic Regimens Reduce Risk of Device-Related Infections?
- Adherence and Intensity of Lipid-Lowering Therapy Influence CV Risk
- Challenges in Weighing Costs, Therapeutic Benefits of Expensive Pharmaceuticals
- Sustained Systolic Blood Pressure Reductions With Barbershop Intervention
- Stethoscopes in ICU Show High Levels of Bacterial Contamination